Abstract
Abstract Since Warburg and his associates reported in 1924 that cancer tissue exhibits a greater rate of aerobic glycolysis than normal tissue, there have been numerous efforts to define enzymatic defects in cancer tissue. Attempts have been made to use enzyme assays in the diagnosis of cancer and in following the course of the disease. This review considers in this regard the role of organ-specific enzymes (amylase, phosphohydrolases, etc.) as well as the more ubiquitous glycolytic enzymes. The usefulness of the assay of isoenzymes in serum, as well as in tissue of cancer patients, is discussed and the role of enzymes in chemotherapy considered
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
